Cargando…
Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340769/ https://www.ncbi.nlm.nih.gov/pubmed/28337173 http://dx.doi.org/10.3389/fneur.2017.00077 |
_version_ | 1782512864080166912 |
---|---|
author | Umakhanova, Zoya R. Bardakov, Sergei N. Mavlikeev, Mikhail O. Chernova, Olga N. Magomedova, Raisat M. Akhmedova, Patimat G. Yakovlev, Ivan A. Dalgatov, Gimat D. Fedotov, Valerii P. Isaev, Artur A. Deev, Roman V. |
author_facet | Umakhanova, Zoya R. Bardakov, Sergei N. Mavlikeev, Mikhail O. Chernova, Olga N. Magomedova, Raisat M. Akhmedova, Patimat G. Yakovlev, Ivan A. Dalgatov, Gimat D. Fedotov, Valerii P. Isaev, Artur A. Deev, Roman V. |
author_sort | Umakhanova, Zoya R. |
collection | PubMed |
description | To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from the Botlikhsky district of Dagestan, where limb-girdle muscle dystrophy type 2B and Miyoshi myopathy were diagnosed in 12 members from three generations of a large Avar family. In 2000, a previously undescribed mutation in the DYSF gene (c.TG573/574AT; p. Val67Asp) was detected in the affected members of this family. Twenty years later, in this work, we re-examine five known and seven newly affected family members previously diagnosed with dysferlinopathy. We observed disease progression in family members who were previously diagnosed and noted obvious clinical polymorphism of the disease. A typical clinical case is provided. |
format | Online Article Text |
id | pubmed-5340769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53407692017-03-23 Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan Umakhanova, Zoya R. Bardakov, Sergei N. Mavlikeev, Mikhail O. Chernova, Olga N. Magomedova, Raisat M. Akhmedova, Patimat G. Yakovlev, Ivan A. Dalgatov, Gimat D. Fedotov, Valerii P. Isaev, Artur A. Deev, Roman V. Front Neurol Neuroscience To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from the Botlikhsky district of Dagestan, where limb-girdle muscle dystrophy type 2B and Miyoshi myopathy were diagnosed in 12 members from three generations of a large Avar family. In 2000, a previously undescribed mutation in the DYSF gene (c.TG573/574AT; p. Val67Asp) was detected in the affected members of this family. Twenty years later, in this work, we re-examine five known and seven newly affected family members previously diagnosed with dysferlinopathy. We observed disease progression in family members who were previously diagnosed and noted obvious clinical polymorphism of the disease. A typical clinical case is provided. Frontiers Media S.A. 2017-03-08 /pmc/articles/PMC5340769/ /pubmed/28337173 http://dx.doi.org/10.3389/fneur.2017.00077 Text en Copyright © 2017 Umakhanova, Bardakov, Mavlikeev, Chernova, Magomedova, Akhmedova, Yakovlev, Dalgatov, Fedotov, Isaev and Deev. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Umakhanova, Zoya R. Bardakov, Sergei N. Mavlikeev, Mikhail O. Chernova, Olga N. Magomedova, Raisat M. Akhmedova, Patimat G. Yakovlev, Ivan A. Dalgatov, Gimat D. Fedotov, Valerii P. Isaev, Artur A. Deev, Roman V. Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title | Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title_full | Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title_fullStr | Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title_full_unstemmed | Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title_short | Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan |
title_sort | twenty-year clinical progression of dysferlinopathy in patients from dagestan |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340769/ https://www.ncbi.nlm.nih.gov/pubmed/28337173 http://dx.doi.org/10.3389/fneur.2017.00077 |
work_keys_str_mv | AT umakhanovazoyar twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT bardakovsergein twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT mavlikeevmikhailo twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT chernovaolgan twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT magomedovaraisatm twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT akhmedovapatimatg twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT yakovlevivana twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT dalgatovgimatd twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT fedotovvaleriip twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT isaevartura twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan AT deevromanv twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan |